Wordt geladen...
Update on ropinirole in the treatment of Parkinson’s disease
Ropinirole is a dopamine agonist, approved for use to treat symptoms of early and advanced Parkinson’s disease, is now available in a 24-hour formulation in addition to the immediate release version. This review discusses the mode of action of ropinirole and compares the pharmacokinetics of both for...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695212/ https://ncbi.nlm.nih.gov/pubmed/19557097 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|